Management of Participants With Low-level Persistent Viremia (ANRS 161 L-VIR)

NCT02247687 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

4

Enrollment

OTHER_GOV

Sponsor class

Stopped Low recruitment of participants for the study

Conditions

HIV-1 Infection
Treatment Resistant Disorders
Viremia

Interventions

DRUG: Protease inhibitor
DRUG: Isentress® (raltegravir)
OTHER: Counseling arm

Sponsor

ANRS, Emerging Infectious Diseases

Collaborators

[object Object]